Huamei Hospital Founder Dr. Edward Reed Wagner Honored in China
NEWS: Dr. Craig Wagner Shinn announces that his great grandfather Dr. Edward Reed Wagner, a missionary doctor in the American Board of Commissioners of Foreign Missions (Global Ministries) in the late 19th century, was honored for founding Huamei Hospital in Linqing, Shandong, China at a special ceremony celebrating the hospital's 130th year on November 1st.
New Children’s Book is Designed to Delight Parents, Typically Developing Kids, and those with ADD/ADHD or Autism Spectrum
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Journey Books, LLC, today announced release of 'Going to Bed is Easy Now' (ISBN: 978-0692357842), first in series of illustrated children's books by Doris and Maritsa Bowman. Written in both English and Spanish editions, the book is designed to ease the stress of everyday activities that create chronically challenging behaviors in typically developing children.
Ophthalmic Pharmaceuticals Company Paragon BioTeck Receives CE Mark Approval on Comfortear Lacrisolve Absorbable Punctum Plug
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear Lacrisolve Absorbable Punctum Plug. CE mark approval is recognized and associated with safety and performance in multiple countries.
Paragon BioTeck, Inc. ormally launching its corporate citizenship initiative coined, Paragon Gives
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announces that it will be formally launching its corporate citizenship initiative coined, Paragon Gives. On Sunday October 19, 2014, Paragon BioTeck, will kick off its newly branded corporate social responsibility initiative at the annual American Academy of Ophthalmology conference in Chicago.
American Academy of Ophthalmology Annual Meeting 2014 to include exhibit from Paragon BioTeck, Inc.
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago on October 18-21, 2014.
Paragon BioTeck Receives 510(k) clearance from the Food and Drug Administration for its Comfortear Lacrisolve Absorbable Punctum Plug
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Oregon's Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug.
Paragon BioTeck's FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available through Bausch + Lomb
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb.
Paragon BioTeck, Inc. receives FDA Approval for Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.
Paragon BioTeck to launch new line of eyecare products at the Annual American Academy of Ophthalmology meeting
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Biopharmaceutical company Paragon BioTeck, Inc. today announced that it plans to launch its new line of products, known as Ilast(R), at the Annual American Academy of Ophthalmology meeting in New Orleans. Paragon signed an exclusive distribution agreement with Horus Pharma to supply Ilast(R) ocular care products in the U.S. last month, and the company is excited to release these products to ophthalmology professionals.
Paragon BioTeck Inc to Distribute Horus Pharma Ilast Ocular Hygiene in U.S. with Exclusive Agreement
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc. signs a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States. It begins on an exclusive basis this month.
